Vikas Sinha

Vikas Sinha has served as Chief Financial Officer of Scholar Rock since April 2025. He brings over 30 years of executive leadership experience in the life sciences industry, with a proven track record across finance, investor relations, business development, strategy, IT, and human resources. Prior to joining Scholar Rock, he co-founded and served as CFO of ElevateBio, where he is currently a Board member and Audit Committee Chair. He also held the roles of President and CFO at AlloVir Inc.

Earlier in his career, Vikas served as CFO at Alexion Pharmaceuticals, where he played a pivotal role in the company’s growth—from a market capitalization of $600 million to over $30 billion, and from no revenue to more than $3 billion annually. Before Alexion, he held multiple leadership positions at Bayer AG across the United States, Japan, Germany, and Canada, including Vice President and CFO of Bayer Pharmaceuticals Corporation (U.S.) and Vice President and CFO of Bayer Yakuhin Ltd. (Japan).

Vikas currently serves as a Board member and Audit Committee Chair at Ray Therapeutics. He holds an MBA from the Asian Institute of Management in Manila, Philippines. He is a qualified Chartered Accountant and an associate member of the Institute of Chartered Accountants of India, as well as a Certified Public Accountant in the U.S.